BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

826 related articles for article (PubMed ID: 19059448)

  • 1. No association of serotonin transporter polymorphism (5-HTTVNTR and 5-HTTLPR) with characteristics and treatment response to atypical antipsychotic agents in schizophrenic patients.
    Lee HY; Kim DJ; Lee HJ; Choi JE; Kim YK
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):276-80. PubMed ID: 19059448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute antipyschotic efficacy and side effects in schizophrenia: association with serotonin transporter promoter genotypes.
    Dolzan V; Serretti A; Mandelli L; Koprivsek J; Kastelic M; Plesnicar BK
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1562-6. PubMed ID: 18573584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of the CYP2D6 polymorphism on psychopathological and extrapyramidal symptoms in the patients on long-term antipsychotic treatment.
    Plesnicar BK; Zalar B; Breskvar K; Dolzan V
    J Psychopharmacol; 2006 Nov; 20(6):829-33. PubMed ID: 16478753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of serotonin transporter gene-linked polymorphic region and variable number of tandem repeat polymorphism of the serotonin transporter gene in lichen simplex chronicus patients with psychiatric status.
    Kirtak N; Inaloz HS; Akçali C; Erdal E; Herken H; Yildirim M; Erguven HG
    Int J Dermatol; 2008 Oct; 47(10):1069-72. PubMed ID: 18986359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between the serotonin transporter gene (5-HTTLPR) and anger-related traits in Korean schizophrenic patients.
    Kim YR; Jahng JW; Min SK
    Neuropsychobiology; 2009; 59(3):165-71. PubMed ID: 19439997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tryptophan hydroxylase and serotonin transporter gene polymorphism does not affect the diagnosis, clinical features and treatment outcome of panic disorder in the Korean population.
    Kim W; Choi YH; Yoon KS; Cho DY; Pae CU; Woo JM
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Dec; 30(8):1413-8. PubMed ID: 16822601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association study between the novel functional polymorphism of the serotonin transporter gene and suicidal behaviour in schizophrenia.
    De Luca V; Zai G; Tharmalingam S; de Bartolomeis A; Wong G; Kennedy JL
    Eur Neuropsychopharmacol; 2006 May; 16(4):268-71. PubMed ID: 16274962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between multidrug resistance 1 (MDR1) gene polymorphisms and therapeutic response to bromperidol in schizophrenic patients: a preliminary study.
    Yasui-Furukori N; Saito M; Nakagami T; Kaneda A; Tateishi T; Kaneko S
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):286-91. PubMed ID: 16386826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of serotonin transporter promoter gene polymorphism (5-HTTLPR) with depression in Costa Rican schizophrenic patients.
    Contreras J; Hernández S; Quezada P; Dassori A; Walss-Bass C; Escamilla M; Raventos H
    J Neurogenet; 2010 Jul; 24(2):83-9. PubMed ID: 20397838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin transporter polymorphisms and early response to antipsychotic treatment in first episode of psychosis.
    Vázquez-Bourgon J; Arranz MJ; Mata I; Pelayo-Terán JM; Pérez-Iglesias R; Medina-González L; Carrasco-Marín E; Vázquez-Barquero JL; Crespo-Facorro B
    Psychiatry Res; 2010 Feb; 175(3):189-94. PubMed ID: 20031235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lack of association between the insertion/deletion polymorphism in the serotonin transporter gene and schizophrenia].
    Kapelski P; Hauser J; Dmitrzak-Weglarz M; Skibińska M; Słopień A; Kaczmarkiewicz-Fass M; Rajewska A; Gattner K; Czerski PM
    Psychiatr Pol; 2006; 40(5):925-35. PubMed ID: 17217236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HTTLPR functional polymorphism in schizophrenia: executive functions vs. sustained attention dissociation.
    Bosia M; Anselmetti S; Pirovano A; Ermoli E; Marino E; Bramanti P; Smeraldi E; Cavallaro R
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):81-5. PubMed ID: 19818823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Association of functional genes polymorphisms of key enzymes in the metabolism of biogenic amines with paranoid schizophrenia susceptibility and the influence of these polymorphisms on PANSS results in antipsychotic treatment].
    Tybura P; Grzywacz A; Syrek S; Parus M; Samochowiec J
    Psychiatr Pol; 2006; 40(5):913-23. PubMed ID: 17217235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response of risperidone treatment may be associated with polymorphisms of HTT gene in Chinese schizophrenia patients.
    Wang L; Yu L; He G; Zhang J; Zhang AP; Du J; Tang RQ; Zhao XZ; Ma J; Xuan JK; Xiao Y; Gu NF; Feng GY; Xu MQ; Xing QH; He L
    Neurosci Lett; 2007 Feb; 414(1):1-4. PubMed ID: 17287080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CNR1 gene as a pharmacogenetic factor for antipsychotics rather than a susceptibility gene for schizophrenia.
    Hamdani N; Tabeze JP; Ramoz N; Ades J; Hamon M; Sarfati Y; Boni C; Gorwood P
    Eur Neuropsychopharmacol; 2008 Jan; 18(1):34-40. PubMed ID: 17669634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No association of antipsychotic agent-induced weight gain with a DA receptor gene polymorphism and therapeutic response.
    Zhang ZJ; Yao ZJ; Zhang XB; Chen JF; Sun J; Yao H; Hou G; Zhang XB
    Acta Pharmacol Sin; 2003 Mar; 24(3):235-40. PubMed ID: 12617772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin transporter polymorphisms: no association with response to antipsychotic treatment, but associations with the schizoparanoid and residual subtypes of schizophrenia.
    Kaiser R; Tremblay PB; Schmider J; Henneken M; Dettling M; Müller-Oerlinghausen B; Uebelhack R; Roots I; Brockmöller J
    Mol Psychiatry; 2001 Mar; 6(2):179-85. PubMed ID: 11317220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of serotonin transporter gene polymorphism in tinnitus.
    Deniz M; Bayazit YA; Celenk F; Karabulut H; Yilmaz A; Gunduz B; Saridogan C; Dagli M; Erdal E; Menevse A
    Otol Neurotol; 2010 Jan; 31(1):19-24. PubMed ID: 19924014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risperidone-related weight gain: genetic and nongenetic predictors.
    Lane HY; Liu YC; Huang CL; Chang YC; Wu PL; Lu CT; Chang WH
    J Clin Psychopharmacol; 2006 Apr; 26(2):128-34. PubMed ID: 16633140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association study of the serotonin transporter promoter polymorphism and mirtazapine antidepressant response in major depressive disorder.
    Kang RH; Wong ML; Choi MJ; Paik JW; Lee MS
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1317-21. PubMed ID: 17618721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.